Free Trial
NYSE:MED

Medifast Q2 2025 Earnings Report

Medifast logo
$14.47 -0.21 (-1.43%)
Closing price 07/11/2025 03:58 PM Eastern
Extended Trading
$14.04 -0.43 (-2.97%)
As of 04:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Medifast EPS Results

Actual EPS
N/A
Consensus EPS
-$0.22
Beat/Miss
N/A
One Year Ago EPS
N/A

Medifast Revenue Results

Actual Revenue
N/A
Expected Revenue
$96.10 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Medifast Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Monday, August 4, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

Medifast Earnings Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Medifast Stock Guidance | NYSE:MED - Benzinga
See More Medifast Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Medifast? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Medifast and other key companies, straight to your email.

About Medifast

Medifast (NYSE:MED), Inc. (NYSE: MED) is a leading health and wellness company specializing in science-based weight‐loss and healthy living solutions. Founded in 1980, the company developed a proprietary program centered on portion‐controlled meal replacements, nutritional supplements and coaching support. Over the years, Medifast has expanded its offerings to include a broader suite of products and services designed to help individuals achieve sustainable health and wellness goals.

The company’s core product portfolio includes a range of meal‐replacement bars, shakes, soups and snacks, along with vitamin and mineral supplements. Medifast’s flagship program, Optavia®, integrates these products into structured daily plans, combining pre-designed “Fuelings” with personalized support from certified health coaches. This approach emphasizes habit formation and lifestyle change, allowing clients to transition from focused weight‐loss phases to longer-term maintenance.

Medifast operates primarily in the United States and Canada, serving customers through a direct-to-consumer model that leverages a network of independent coaches. These coaches provide one-on-one guidance through in-person sessions, phone calls and a comprehensive digital platform. The company’s distribution network enables timely delivery of products nationwide, while its online portal and mobile applications facilitate client engagement, progress tracking and community support.

Under the leadership of President and Chief Executive Officer Daniel Chard, Medifast continues to invest in research, product innovation and technology enhancements. The company’s management team and board of directors bring deep expertise in nutrition science, consumer marketing and digital health. Medifast’s commitment to rigorous quality standards and ongoing program refinement has established it as a trusted partner for individuals seeking effective, long-term health and weight-management solutions.

View Medifast Profile

More Earnings Resources from MarketBeat